Click on the links or scroll down the page for information about work currently in progress by category. Please note that information summarised on this page is subject to change.
We produce prescribing guidance and other medicines resources to help patients and healthcare professionals in Wales make sure that medicines are used effectively and appropriately. When we produce these resources, we think it's important that people who might be affected by them have a chance to tell us their views.
We ask patients and carers, patient organisations, prescribers and other healthcare professionals to comment on the resources we're developing. We'd like your views on the resources we're currently working on, listed below. You don't need to comment on the whole document; only on parts that seem relevant to you.
|
Title: National Prescribing Indicators 2025-2028 Status: Consultation open Remit: The review and update of NPIs now takes place every three years to enable health boards to develop long-term plans for utilising NPIs to make measurable improvements in prescribing. The development of the NPIs for 2025–2028 takes into consideration the overall goals and objectives set in the AWMSG Strategy for Wales: 2024–2029. Estimated publication date: September 2024–November 2024 |
|
Title: Prescribing of Branded Generics - Position Statement Status: Consultation open Remit: This statement has been developed to provide clear direction to prescribers across Wales of the requirement to prescribe generically (e.g. use a medicine’s generic name when prescribing), unless there is a clinical reason to prescribe by brand (e.g. branded or branded generic prescribing). Health boards and Trusts across Wales are required to support prescribers with respect to this position. Estimated publication date: September 2024–November 2024 |
Patients, carers and patient organisations - please see our New medicines needing your views page for answers to some questions you might have about making a submission.
Clinical experts - please see our Clinical expert opinion for medicine appraisals page for background information.
We'd like to receive your submission before the stated deadline (so we can prepare the meeting papers). But we'll still try to include any that arrive late.
|
Medicine name: emtricitabine/tenofovir alafenamide fumarate (Descovy®) Reference number: 2566 Indication: Pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in at‑risk men who have sex with men, including adolescents (with body weight at least 35 kg). Patient and carer submission: Download form or submit online Patient organisation submission: Download form or submit online Clinical experts submission: Download form Submission deadline: 07/05/2023 |
|
Title: Initial clinical management of nicotine withdrawal in adults in secondary care Status: Consultation completed Remit: This is an update to the document ‘Initial clinical management of adult smokers in secondary care’. The document gives information and guidance on the initiation of nicotine replacement therapy (NRT) in secondary care settings in NHS Wales, for management of nicotine withdrawal in adults who smoke. It has been reviewed and updated to include information on the use of vapes. Estimated publication date: September 2024-November 2024 |
|
Title: All Wales guidance for penicillin allergy de-labelling Status: Consultation completed Remit: This document provides information and guidance on the identification and removal of penicillin allergy labels in adults who have not experienced a true hypersensitivity reaction. This guidance is only intended for use in patients reporting a penicillin allergy in secondary care settings in NHS Wales. Estimated publication date: June 2024-August 2024 |
|
Title: Back-up antibiotic prescribing: Good practice guide Status: Consultation completed Remit: The aim of this document is to provide an All-Wales Good Practice Guide for the implementation of back-up prescribing strategies in primary and community care. It contains advice on when back-up prescribing should be considered, the strategies available and how this should be documented. Estimated publication date: September 2024-November 2024 |
|
Title: National Prescribing Indicators 2025-2028 Status: Consultation open Remit: The review and update of NPIs now takes place every three years to enable health boards to develop long-term plans for utilising NPIs to make measurable improvements in prescribing. The development of the NPIs for 2025–2028 takes into consideration the overall goals and objectives set in the AWMSG Strategy for Wales: 2024–2029. Estimated publication date: September 2024–November 2024 |
|
Title: Prescribing of Branded Generics - Position Statement Status: Consultation open Remit: This statement has been developed to provide clear direction to prescribers across Wales of the requirement to prescribe generically (e.g. use a medicine’s generic name when prescribing), unless there is a clinical reason to prescribe by brand (e.g. branded or branded generic prescribing). Health boards and Trusts across Wales are required to support prescribers with respect to this position. Estimated publication date: September 2024–November 2024 |
|
Title: All Wales Medicine Management Guidelines for Integrated Community Based Services Status: Consultation completed Remit: This guideline is focused on community care and designed to address the unique needs and challenges faced by registered service providers ensuring consistent medicine advice in diverse care settings. Specifically designed to guide local policy development, this guideline aims to establish a unified and integrated policy across health and social care, providing comprehensive guidance for medicine optimisation. |
No assessments are currently underway.
|
Title: Review of AWMSG processes to support medicines access in NHS Wales Summary: Revision of processes to improve access to medicines Estimated publication date: Summer/Autumn 2024 Document: Review of AWMSG processes to support medicines access in NHS Wales (PDF, 54Kb) |
|
Title: AWMSG annual report 2023-2024 Summary: Review of the activities and achievements of the All Wales Medicine Strategy Group (AWMSG) between April 2023 and March 2024. Estimated publication date: September 2024 |
|
Title: IPFR annual report 2023-2024 Summary: Review of Individual Patient Funding Request activity in Wales between April 2023 and March 2024. Estimated publication date: September 2024 |